136 related articles for article (PubMed ID: 28294054)
1. Recent Advances in Preclinical Studies and Potential Applications of Dendrimers as Drug Carriers in the Central Nervous System.
Gagliardi M
Curr Pharm Des; 2017; 23(21):3105-3119. PubMed ID: 28294054
[TBL] [Abstract][Full Text] [Related]
2. Poly(amido amine) dendrimers in oral delivery.
Yellepeddi VK; Ghandehari H
Tissue Barriers; 2016; 4(2):e1173773. PubMed ID: 27358755
[TBL] [Abstract][Full Text] [Related]
3. Dendrimer advances for the central nervous system delivery of therapeutics.
Xu L; Zhang H; Wu Y
ACS Chem Neurosci; 2014 Jan; 5(1):2-13. PubMed ID: 24274162
[TBL] [Abstract][Full Text] [Related]
4. PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice.
Srinageshwar B; Peruzzaro S; Andrews M; Johnson K; Hietpas A; Clark B; McGuire C; Petersen E; Kippe J; Stewart A; Lossia O; Al-Gharaibeh A; Antcliff A; Culver R; Swanson D; Dunbar G; Sharma A; Rossignol J
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335421
[TBL] [Abstract][Full Text] [Related]
5. Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier.
Hemmer R; Hall A; Spaulding R; Rossow B; Hester M; Caroway M; Haskamp A; Wall S; Bullen HA; Morris C; Haik KL
Molecules; 2013 Sep; 18(9):11537-52. PubMed ID: 24048286
[TBL] [Abstract][Full Text] [Related]
6. Dendrimers as vectors for genetic material delivery to the nervous system.
Pérez-Martínez FC; Ocaña AV; Pérez-Carrión MD; Ceña V
Curr Med Chem; 2012; 19(29):5101-8. PubMed ID: 22963638
[TBL] [Abstract][Full Text] [Related]
7. Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model.
Sharma A; Porterfield JE; Smith E; Sharma R; Kannan S; Kannan RM
J Control Release; 2018 Aug; 283():175-189. PubMed ID: 29883694
[TBL] [Abstract][Full Text] [Related]
8. Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.
Zhang F; Mastorakos P; Mishra MK; Mangraviti A; Hwang L; Zhou J; Hanes J; Brem H; Olivi A; Tyler B; Kannan RM
Biomaterials; 2015 Jun; 52():507-16. PubMed ID: 25818456
[TBL] [Abstract][Full Text] [Related]
9. Transepithelial and endothelial transport of poly (amidoamine) dendrimers.
Kitchens KM; El-Sayed ME; Ghandehari H
Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433
[TBL] [Abstract][Full Text] [Related]
10. Polymer Nanoparticles as Smart Carriers for the Enhanced Release of Therapeutic Agents to the CNS.
Gagliardi M; Borri C
Curr Pharm Des; 2017; 23(3):393-410. PubMed ID: 27799038
[TBL] [Abstract][Full Text] [Related]
11. Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids.
Bugno J; Hsu HJ; Pearson RM; Noh H; Hong S
Mol Pharm; 2016 Jul; 13(7):2155-63. PubMed ID: 26828309
[TBL] [Abstract][Full Text] [Related]
12. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer-mediated approaches for the treatment of brain tumor.
Dwivedi N; Shah J; Mishra V; Mohd Amin MC; Iyer AK; Tekade RK; Kesharwani P
J Biomater Sci Polym Ed; 2016; 27(7):557-80. PubMed ID: 26928261
[TBL] [Abstract][Full Text] [Related]
14. Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain.
Beg S; Samad A; Alam MI; Nazish I
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):576-88. PubMed ID: 21631401
[TBL] [Abstract][Full Text] [Related]
15. A Robust Intrinsically Green Fluorescent Poly(Amidoamine) Dendrimer for Imaging and Traceable Central Nervous System Delivery in Zebrafish.
Wang G; Zhao X; Wu H; Lovejoy DB; Zheng M; Lee A; Fu L; Miao K; An Y; Sayyadi N; Ding K; Chung RS; Lu Y; Li J; Morsch M; Shi B
Small; 2020 Oct; 16(39):e2003654. PubMed ID: 32875740
[TBL] [Abstract][Full Text] [Related]
16. Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers.
Kojima C; Regino C; Umeda Y; Kobayashi H; Kono K
Int J Pharm; 2010 Jan; 383(1-2):293-6. PubMed ID: 19761822
[TBL] [Abstract][Full Text] [Related]
17. Dendrimer technologies for brain tumor.
Mishra V; Kesharwani P
Drug Discov Today; 2016 May; 21(5):766-78. PubMed ID: 26891979
[TBL] [Abstract][Full Text] [Related]
18. In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry.
Albertazzi L; Gherardini L; Brondi M; Sulis Sato S; Bifone A; Pizzorusso T; Ratto GM; Bardi G
Mol Pharm; 2013 Jan; 10(1):249-60. PubMed ID: 23163881
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
[TBL] [Abstract][Full Text] [Related]
20. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
